Showing results (261-270 of 1,831) with videos related to

Sort By:
Pageof 184
ESMO Open|December 7, 2017
Second-line treatments: moving towards an opportunity to improve survival in advanced gastric cancer?Massimiliano Salati, Katia Di Emidio, Vittoria Tarantino, et al.
ESMO Open|December 7, 2017
Heterogeneity of colon cancer: from bench to bedsideMarco C Merlano, Cristina Granetto, Elena Fea, et al.
ESMO Open|December 7, 2017
Do patients with reduced or excellent performance status derive the same clinical benefit from novel systemic cancer therapies? A systematic review and meta-analysisSierra Cheng, Mahin Qureshi, Eleanor Pullenayegum, et al.
ESMO Open|December 7, 2017
Activating HER2 mutations as emerging targets in multiple solid cancersClaire M Connell, Gary J Doherty
ESMO Open|December 8, 2017
Proxies of quality of life in metastatic colorectal cancer: analyses in the RECOURSE trialEric Van Cutsem, Alfredo Falcone, Rocio Garcia-Carbonero, et al.
ESMO Open|July 19, 2018
Phase I study of TrasGEX, a glyco-optimised anti-HER2 monoclonal antibody, in patients with HER2-positive solid tumoursWalter Fiedler, Herbert Stoeger, Antonella Perotti, et al.
ESMO Open|July 19, 2018
2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcomaAnna Maria Frezza, Alex T J Lee, Eran Nizri, et al.
ESMO Open|July 19, 2018
Choosing wisely in oncology: necessity and obstaclesPiercarlo Saletti, Piero Sanna, Luca Gabutti, et al.
ESMO Open|August 18, 2018
Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer: initial results from the observational AQUARiUS studyAntoine Thiery-Vuillemin, Mads Hvid Poulsen, Edouard Lagneau, et al.
ESMO Open|June 27, 2018
Clonal evolution of colorectal cancer in a patient with serially resected metastases and liquid biopsies: a case report and discussion of the literatureMyrto Kastrisiou, George Zarkavelis, Eleftherios Kampletsas, et al.
Pageof 184